Navigation Links
Sunrise Pharmaceutical, Inc. Sued for Violation of New Jersey Consumer Fraud Act
Date:9/17/2013

ESTERO, Fla., Sept. 17, 2013 /PRNewswire/ -- Vision Pharma, LLC has initiated a civil action against Sunrise Pharmaceutical, Inc. of Rahway, New Jersey in U.S. District Court for the District of New Jersey, Trenton Division. The nine-count lawsuit seeks to recover at least $3 million from Sunrise Pharmaceutical, plus statute-imposed, mandatory treble damages and attorney fees pursuant to NJ Stat. Ann. § 56:8-19, stemming from Sunrise Pharmaceutical's defective manufacture of certain drug products deemed adulterated and unsalable by the U.S. Food & Drug Administration (FDA) as well as Sunrise Pharmaceutical's willful sale of said adulterated drugs to Vision Pharma without notice of the FDA's investigations and determinations.  The case is styled Vision Pharma, LLC v. Sunrise Pharmaceutical Inc., C.A. No. 2:13-cv-04692-CCC-JAD and is now pending before the Hon. Claire C. Cecchi.

A full list of the nine (9) causes of action asserted by Vision Pharma upon which it seeks relief from the U.S. District Court is as follows:

Count 1:  Violation of New Jersey Consumer Fraud Act
Count 2:  Breach of Contract
Count 3:  Willful Breach of Implied Warranty of Merchantability
Count 4:  Breach of Implied Warranty of Fitness for a Particular Purpose
Count 5:  Breach of Covenant of Good Faith and Fair Dealing
Count 6:  Unjust Enrichment
Count 7:  Negligence
Count 8:  Deceptive Trade Practices
Count 9:  Fraud & Deceit

"It is very unfortunate that we had to file suit against Sunrise Pharmaceutical after numerous attempts to resolve these issues amicably; however, the severe damage they caused our company left this as the only option.  We are certainly prepared for a trial by jury and taking this case to the end for a well-deserved victory," said Sander S. Busman, Founder, President & CEO, Vision Pharma.  Vision Pharma is being represented by lead counsel Cameron S. Reuber, Esq. and a team of attorneys at Leason Ellis LLP.

About Vision Pharma
Vision Pharma specializes in niche, generic pharmaceuticals with various delivery options and dosage forms. The company provides quality products at competitive prices while improving the lives of those who take their medicines. The organization's customer service acts promptly to requests while continuously improving to fulfill each customer and patient need. Maintaining additional inventory ensures Vision's ability to provide increased service levels. The pipeline of generic pharmaceuticals planned to market continues to be a strong focus internally and with other pharmaceutical organizations, domestically and internationally. Valuable relationships that are built show true dedication to each partnering company. You can count on Vision Pharma to consider the patient's safety as a top priority when developing and manufacturing their items. To learn more, please visit www.visionpharma.com.

Media Relations Contact:
Sander S. Busman                                                                  
Vision Pharma
Founder, President & CEO
sbusman@visionpharma.com

 


'/>"/>
SOURCE Vision Pharma
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray
2. New Air Products Microsite Features Advanced Liquid Nitrogen Solutions for the Chemical, Pharmaceutical, and Life Science Industries
3. Bernstein Liebhard LLP Announces That A Securities Class Action Has Been Filed Against Aveo Pharmaceutical, Inc.
4. Earnings Forecast Stock Alerts: American International Group, Teva Pharmaceutical, CSX, Exxon Mobil, Lowes, and Seagate
5. CorePharma Addresses Violations in FDA Warning Letter
6. Federal Government Targets Small, Mid-sized Practices for Probes of Patient Privacy Violations
7. Cardiac Science signs contract to provide Powerheart AEDs to the state of New Jersey
8. Big Pharma to Come Together at ChemOutsourcing 2013 in Long Branch, New Jersey, Sept 16-19
9. ChemOutsourcing Announces 100 CMO and CRO Exhibitors for September 2013 Show in Long Branch, New Jersey
10. ChemOutsourcing Announces 30 Pharma Company Presenters for September 2013 Outsourcing Show in New Jersey
11. NJBIZ Honors New Jerseys General Counsels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... TapImmune,Inc. (TPIV), a clinical-stage immune-oncology company ... and vaccines for the treatment of cancer & metastatic disease, ... Growth Capital Expo to be held on May 3 ... in Las Vegas, Nevada.  The Company presentation will be ... by Dr. John N. Bonfiglio a TapImmune Board ...
(Date:4/27/2016)... 27, 2016   ... in Recurring Consumable Sales  Clinical sales grow ... Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the ... for the first quarter ended March 31, 2016 and ... of its commercial strategy. First Quarter 2016 ...
(Date:4/27/2016)... April 27, 2016  Bayer Animal Health today ... from the University of Florida College of Veterinary ... Excellence in Communication Award (BECA). Brittany was selected ... awarded a total of $70,000 in scholarship funds ... years, Bayer has provided a total of $232,500 ...
Breaking Medicine Technology:
(Date:4/29/2016)... (PRWEB) , ... April 30, 2016 , ... ... engineer of patented products, announces the Pick Up Springboard, an automotive invention that ... Light Truck Manufacturing industry is worth $162 billion," says Scott Cooper, CEO and ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Awakening , announces the addition Onnit brand Alpha BRAIN and New Mood Daily-Stress ... Onnit brain and mood optimization products to the store is just one more ...
(Date:4/29/2016)... VA (PRWEB) , ... April 29, 2016 , ... ... with student loans more flexibility in repaying their loans, more information about their ... a time when total outstanding student loan debt, including federal and private loans, ...
(Date:4/29/2016)... Philadelphia, PA (PRWEB) , ... April 29, 2016 ... ... Pennsylvania announced that student team BioCellection won the $30,000 Perlman Grand Prize of ... Impact Prize, the Gloeckner Undergraduate Award, the Michelson People‚Äôs Choice Award, and the ...
(Date:4/29/2016)... , ... April 29, 2016 , ... Dr. Robert Mondavi, ... treatments to improve smiles. Cosmetic dentistry is a fast-growing field as more patients are ... allows patients to learn more about the options currently available to them and which ...
Breaking Medicine News(10 mins):